ARTICLE | Company News
Oxxon Pharmaccines receives license
September 7, 2000 7:00 AM UTC
Imperial College Innovations (London, U.K.) granted Oxxon (Oxford, U.K.) a worldwide license to use its TRAP DNA, which encodes an antigen from the malaria parasite Plasmodium falciparum, with Oxxon's...